Cavitary tuberculosis: the gateway of disease transmission (Q96121872)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32482293%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

title

Cavitary tuberculosis: the gateway of disease transmission (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32482293%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

William R Bishai

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32482293%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Michael E Urbanowski

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32482293%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Alvaro A Ordonez

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32482293%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Camilo A Ruiz-Bedoya

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32482293%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Sanjay K Jain

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32482293%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

5 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32482293%20AND%20SRC:MED&resulttype=core&format=json

Lancet Infectious Diseases

7 June 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32482293%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32482293%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32482293%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

e117-e128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32482293%20AND%20SRC:MED&resulttype=core&format=json

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Cavitary disease and quantitative sputum bacillary load in cases of pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Mycobacterium tuberculosis in the Extracellular Compartment: an Underestimated Adversary

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Additional drug resistance in Mycobacterium tuberculosis isolates from resected cavities among patients with multidrug-resistant or extensively drug-resistant pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Prediction of Drug Penetration in Tuberculosis Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

The association between sterilizing activity and drug distribution into tuberculosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Long term complications after completion of pulmonary tuberculosis treatment: A quest for a public health approach

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Risk factors for pulmonary cavitation in tuberculosis patients from China

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Clonal Population of Mycobacterium tuberculosis Strains Reside within Multiple Lung Cavities

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

New insights into the function of granulomas in human tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Radiographic spectrum of adult pulmonary tuberculosis in a developed country

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Pulmonary tuberculosis: relationship between sputum bacilloscopy and radiological lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Radiological manifestations of pulmonary tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Update: the radiographic features of pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Tuberculosis in the normal host: radiological findings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Pulmonary tuberculosis: CT findings--early active disease and sequential change with antituberculous therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Glycemic control and radiographic manifestations of tuberculosis in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

The effect of HIV and antiretroviral therapy on characteristics of pulmonary tuberculosis in northern Malawi: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Clinical investigation of cavitary tuberculosis and tuberculous pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

High-resolution CT findings of pulmonary Mycobacterium tuberculosis infection in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Mycobacterium tuberculosis Beijing genotype is an independent risk factor for tuberculosis treatment failure in Indonesia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Tuberculosis associated with Mycobacterium tuberculosis Beijing and non-Beijing genotypes: a clinical and immunological comparison

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

RDRio Mycobacterium tuberculosis infection is associated with a higher frequency of cavitary pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Surgical treatment of complications of pulmonary tuberculosis, including drug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Cough Frequency During Treatment Associated With Baseline Cavitary Volume and Proximity to the Airway in Pulmonary TB.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

The association between symptoms and microbiologically defined response to tuberculosis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Tuberculosis Infectiousness and Host Susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Whole-genome sequencing and social-network analysis of a tuberculosis outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Transforming the fight against tuberculosis: targeting catalysts of transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Cavitary pulmonary disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

High-resolution CT findings in patients with pulmonary tuberculosis: correlation with the degree of smear positivity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Radiographic appearance of pulmonary tuberculosis: dogma disproved

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Clinical and radiographic correlates of primary and reactivation tuberculosis: a molecular epidemiology study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Chest radiographic findings in primary pulmonary tuberculosis: observations from high school outbreaks

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

The TB Portals: an Open-Access, Web-Based Platform for Global Drug-Resistant-Tuberculosis Data Sharing and Analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Pulmonary tuberculosis: the essentials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

THE FOCAL PULMONARY TUBERCULOSIS OF CHILDREN AND ADULTS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Apical localization of pulmonary tuberculosis, chronic pulmonary histoplasmosis, and progressive massive fibrosis of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Pathogenesis of tuberculosis: pathway to apical localization

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

The ongoing challenge of latent tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

A sterilizing tuberculosis treatment regimen is associated with faster clearance of bacteria in cavitary lesions in marmosets

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Mouse model of pulmonary cavitary tuberculosis and expression of matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Modeling tuberculosis in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Radiologic Responses in Cynomolgus Macaques for Assessing Tuberculosis Chemotherapy Regimens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Experimental pulmonary cavity formation by mycobacterial components and synthetic adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Repetitive Aerosol Exposure Promotes Cavitary Tuberculosis and Enables Screening for Targeted Inhibitors of Extensive Lung Destruction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Progression to tuberculosis disease increases with multiple exposures

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Mycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

A modified scoring system to describe gross pathology in the rabbit model of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Extrapulmonary dissemination of Mycobacterium bovis but not Mycobacterium tuberculosis in a bronchoscopic rabbit model of cavitary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Pharmacokinetics of rifapentine and rifampin in a rabbit model of tuberculosis and correlation with clinical trial data.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Ipr1 gene mediates innate immunity to tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Is tuberculosis a lymphatic disease with a pulmonary portal?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Inflammatory signaling in human tuberculosis granulomas is spatially organized

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

HYDROLYTIC ENZYMES OF RABBIT MONONUCLEAR EXUDATE CELLS. I. QUANTITATIVE ASSAY AND PROPERTIES OF CERTAIN PROTEASES, NON-SPECIFIC ESTERASES, AND LIPASES OF MONONUCLEAR AND POLYMORPHONUCLEAR CELLS AND ERYTHROCYTES

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

MMP-1 drives immunopathology in human tuberculosis and transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Cathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Tuberculosis, pulmonary cavitation, and matrix metalloproteinases.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Neutrophil-Derived MMP-8 Drives AMPK-Dependent Matrix Destruction in Human Pulmonary Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Matrix Metalloproteinases in Pulmonary and Central Nervous System Tuberculosis—A Review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Induced sputum MMP-1, -3 & -8 concentrations during treatment of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Matrix Metalloproteinase Inhibition in a Murine Model of Cavitary Tuberculosis Paradoxically Worsens Pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Diverse cavity types and evidence that mechanical action on the necrotic granuloma drives tuberculous cavitation.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Mathematical Model of Oxygen Transport in Tuberculosis Granulomas

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

The spectrum of latent tuberculosis: rethinking the biology and intervention strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

The tuberculosis necrotizing toxin kills macrophages by hydrolyzing NAD

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Transmission phenotype of Mycobacterium tuberculosis strains is mechanistically linked to induction of distinct pulmonary pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Mycobacterial trehalose dimycolate reprograms macrophage global gene expression and activates matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Immune Response to Mycobacterium tuberculosis: A Narrative Review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Lung remodeling in pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Tuberculosis and lung damage: from epidemiology to pathophysiology.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Dominant role of the sst1 locus in pathogenesis of necrotizing lung granulomas during chronic tuberculosis infection and reactivation in genetically resistant hosts.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Cytokine levels correlate with a radiologic score in active pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Synergistic up-regulation of epithelial cell matrix metalloproteinase-9 secretion in tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Neutrophil extracellular traps are induced by Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Neutrophil extracellular traps: double-edged swords of innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Tuberculosis: An Infection-Initiated Autoimmune Disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Tolerating the Unwelcome Guest; How the Host Withstands Persistent

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Beyond Killing : Disease Tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

The prognosis of a positive tuberculin reaction in childhood and adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Latent tuberculosis infection: myths, models, and molecular mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Mycobacterial Biofilms: Revisiting Tuberculosis Bacilli in Extracellular Necrotizing Lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Resuscitation-promoting factors are important determinants of the pathophysiology in Mycobacterium tuberculosis infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

The enduring hypoxic response of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding α-crystallin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Functional regulation of the opposing (p)ppGpp synthetase/hydrolase activities of RelMtb from Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

The Stringent Response Is Required for Full Virulence ofMycobacterium tuberculosisin Guinea Pigs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Resuscitation-promoting factors reveal an occult population of tubercle Bacilli in Sputum.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Drug-Penetration Gradients Associated with Acquired Drug Resistance in Patients with Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Multiple M. tuberculosis phenotypes in mouse and guinea pig lung tissue revealed by a dual-staining approach

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

A new unifying theory of the pathogenesis of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Postprimary Tuberculosis and Macrophage Necrosis: Is There a Big ConNECtion?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Surgical treatment of drug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Surgical interventions for drug-resistant tuberculosis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

A nested case-control study on treatment-related risk factors for early relapse of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Risk factors for 1-year relapse of pulmonary tuberculosis treated with a 6-month daily regimen

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Lung Tissue Concentrations of Pyrazinamide among Patients with Drug-Resistant Pulmonary Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

A review of 138 cases of closure of tuberculous lung cavities under chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Healing mechanisms of tuberculous cavities

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

[Frequency and morphology of tuberculosis in autopsies: increase of active forms]

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021

Improvement in tubercular cavities following adjuvant treatment with endobronchial valves: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2820%2930148-1

7 January 2021